A study reveals how gender and race influence food insecurity’s impact on cardiovascular disease risk factors among U.S. adults. Key findings and implications.
Lilly’s diabetes and obesity leader to retire in broader leadership shuffle as CSO Dan Skovronsky takes on immunology role
As Eli Lilly anticipates an FDA weight loss approval for its in-demand diabetes drug Mounjaro by year’s end, the drugmaker’s leader of those two areas
October 5, 2023